Preferential Metabolic Activation of N-Nitrosopiperidine as Compared to Its Structural Homologue N-Nitrosopyrrolidine by Rat Nasal Mucosal Microsomes

N-Nitrosopiperidine (NPIP) is a potent rat nasal carcinogen whereas N-nitrosopyrrolidine (NPYR), a hepatic carcinogen, is weakly carcinogenic in the nose. NPIP and NPYR may be causative agents in human cancer. P450-catalyzed α-hydroxylation is the key activation pathway by which these nitrosamines e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemical research in toxicology 2003-10, Vol.16 (10), p.1298-1305
Hauptverfasser: Wong, Hansen L, Murphy, Sharon E, Hecht, Stephen S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1305
container_issue 10
container_start_page 1298
container_title Chemical research in toxicology
container_volume 16
creator Wong, Hansen L
Murphy, Sharon E
Hecht, Stephen S
description N-Nitrosopiperidine (NPIP) is a potent rat nasal carcinogen whereas N-nitrosopyrrolidine (NPYR), a hepatic carcinogen, is weakly carcinogenic in the nose. NPIP and NPYR may be causative agents in human cancer. P450-catalyzed α-hydroxylation is the key activation pathway by which these nitrosamines elicit their carcinogenic effects. We hypothesize that the differences in NPIP and NPYR metabolic activation in the nasal cavity contribute to their differing carcinogenic activities. In this study, the kinetics of tritium-labeled NPIP or NPYR α-hydroxylation mediated by Sprague−Dawley rat nasal olfactory or respiratory microsomes were investigated. To compare α-hydroxylation rates of the two nitrosamines, tritiated 2-hydroxytetrahydro-2H-pyran and 2-hydroxy-5-methyltetrahydrofuran, the major NPIP α-hydroxylation products, and tritiated 2-hydroxytetrahydrofuran, the major NPYR α-hydroxylation product, were quantitated by HPLC with UV absorbance and radioflow detection. These microsomes catalyzed the α-hydroxylation of NPIP more efficiently than that of NPYR. K M values for NPIP were lower as compared to those for NPYR (13.9−34.7 vs 484−7660 μM). Furthermore, catalytic efficiencies (V max/K M) of NPIP were 20−37-fold higher than those of NPYR. Previous studies showed that P450 2A3, present in the rat nose, also exhibited this difference in catalytic efficiency. For both types of nasal microsomes, coumarin (100 μM), a P450 2A inhibitor, inhibited NPIP and NPYR α-hydroxylation from 63.8 to 98.5%. Furthermore, antibodies toward P450 2A6 inhibited nitrosamine α-hydroxylation in these microsomes from 68.8 to 78.4% whereas antibodies toward P450 2E1 did not inhibit these reactions. Further immunoinhibition studies suggest some role for P450 2G1 in NPIP metabolism by olfactory microsomes. In conclusion, olfactory and respiratory microsomes from rat nasal mucosa preferentially activate NPIP over NPYR with P450 2A3 likely playing a key role. These results are consistent with local metabolic activation of nitrosamines as a contributing factor in their tissue-specific carcinogenicity.
doi_str_mv 10.1021/tx0340495
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19179823</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19179823</sourcerecordid><originalsourceid>FETCH-LOGICAL-a380t-f24dc62fc1d73fd7cde9fff4309df00351018bf980a1208520da1df4048900413</originalsourceid><addsrcrecordid>eNptkU1PGzEQhi3UqgTaQ_9A5UuROCwd27vx7hGiEpBomvIh9WY5_qhMd9eL7a3ID-H_4pCI9tDTHOaZd0bPIPSRwAkBSr6kR2AllE21hyakolBUQOANmkDdsILS-uc-OojxHoBknL9D-6SsphXnZIKelsFYE0yfnGzxN5PkyrdO4VOV3B-ZnO-xt3hRLFwKPvrBDSY47XqDZcQz3w0yGI2Tx5cp4psURpXGkJMufOdb_2s0_8yuQ8jZL8OrNb6WCS9k3GwdlX-pTm24zsT36K2VbTQfdvUQ3Z1_vZ1dFFff55ez06tCshpSYWmp1ZRaRTRnVnOlTWOtLRk02gKwigCpV7apQRIKdTajJdE2q6obgJKwQ3S0zR2CfxhNTKJzUZm2lb3xYxSkIbypKcvg8RbcXBizMjEE18mwFgTE5gfi9QeZ_bQLHVed0X_JnfQMFFvAxWQeX_sy_BZTznglbpc3YvmDLvn8ei7OMv95y0sVxb0fQ5-d_GfxM2bGn1g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19179823</pqid></control><display><type>article</type><title>Preferential Metabolic Activation of N-Nitrosopiperidine as Compared to Its Structural Homologue N-Nitrosopyrrolidine by Rat Nasal Mucosal Microsomes</title><source>MEDLINE</source><source>ACS Publications</source><creator>Wong, Hansen L ; Murphy, Sharon E ; Hecht, Stephen S</creator><creatorcontrib>Wong, Hansen L ; Murphy, Sharon E ; Hecht, Stephen S</creatorcontrib><description>N-Nitrosopiperidine (NPIP) is a potent rat nasal carcinogen whereas N-nitrosopyrrolidine (NPYR), a hepatic carcinogen, is weakly carcinogenic in the nose. NPIP and NPYR may be causative agents in human cancer. P450-catalyzed α-hydroxylation is the key activation pathway by which these nitrosamines elicit their carcinogenic effects. We hypothesize that the differences in NPIP and NPYR metabolic activation in the nasal cavity contribute to their differing carcinogenic activities. In this study, the kinetics of tritium-labeled NPIP or NPYR α-hydroxylation mediated by Sprague−Dawley rat nasal olfactory or respiratory microsomes were investigated. To compare α-hydroxylation rates of the two nitrosamines, tritiated 2-hydroxytetrahydro-2H-pyran and 2-hydroxy-5-methyltetrahydrofuran, the major NPIP α-hydroxylation products, and tritiated 2-hydroxytetrahydrofuran, the major NPYR α-hydroxylation product, were quantitated by HPLC with UV absorbance and radioflow detection. These microsomes catalyzed the α-hydroxylation of NPIP more efficiently than that of NPYR. K M values for NPIP were lower as compared to those for NPYR (13.9−34.7 vs 484−7660 μM). Furthermore, catalytic efficiencies (V max/K M) of NPIP were 20−37-fold higher than those of NPYR. Previous studies showed that P450 2A3, present in the rat nose, also exhibited this difference in catalytic efficiency. For both types of nasal microsomes, coumarin (100 μM), a P450 2A inhibitor, inhibited NPIP and NPYR α-hydroxylation from 63.8 to 98.5%. Furthermore, antibodies toward P450 2A6 inhibited nitrosamine α-hydroxylation in these microsomes from 68.8 to 78.4% whereas antibodies toward P450 2E1 did not inhibit these reactions. Further immunoinhibition studies suggest some role for P450 2G1 in NPIP metabolism by olfactory microsomes. In conclusion, olfactory and respiratory microsomes from rat nasal mucosa preferentially activate NPIP over NPYR with P450 2A3 likely playing a key role. These results are consistent with local metabolic activation of nitrosamines as a contributing factor in their tissue-specific carcinogenicity.</description><identifier>ISSN: 0893-228X</identifier><identifier>EISSN: 1520-5010</identifier><identifier>DOI: 10.1021/tx0340495</identifier><identifier>PMID: 14565771</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Aryl Hydrocarbon Hydroxylases - antagonists &amp; inhibitors ; Aryl Hydrocarbon Hydroxylases - metabolism ; Catalysis ; Chromatography, High Pressure Liquid ; Cytochrome P-450 CYP2A6 ; Enzyme Inhibitors - pharmacology ; Humans ; Hydroxylation - drug effects ; Immunoglobulin G - immunology ; Immunoglobulin G - pharmacology ; Kinetics ; Male ; Microsomes - drug effects ; Microsomes - enzymology ; Microsomes - metabolism ; Mixed Function Oxygenases - antagonists &amp; inhibitors ; Mixed Function Oxygenases - metabolism ; Molecular Structure ; N-Nitrosopiperidine ; N-Nitrosopyrrolidine ; N-Nitrosopyrrolidine - chemistry ; N-Nitrosopyrrolidine - metabolism ; N-Nitrosopyrrolidine - toxicity ; Nasal Mucosa - cytology ; Nasal Mucosa - drug effects ; Nasal Mucosa - enzymology ; Nasal Mucosa - metabolism ; Nitrosamines - chemistry ; Nitrosamines - metabolism ; Nitrosamines - toxicity ; Rats ; Rats, Sprague-Dawley</subject><ispartof>Chemical research in toxicology, 2003-10, Vol.16 (10), p.1298-1305</ispartof><rights>Copyright © 2003 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a380t-f24dc62fc1d73fd7cde9fff4309df00351018bf980a1208520da1df4048900413</citedby><cites>FETCH-LOGICAL-a380t-f24dc62fc1d73fd7cde9fff4309df00351018bf980a1208520da1df4048900413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/tx0340495$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/tx0340495$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,777,781,2752,27057,27905,27906,56719,56769</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14565771$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wong, Hansen L</creatorcontrib><creatorcontrib>Murphy, Sharon E</creatorcontrib><creatorcontrib>Hecht, Stephen S</creatorcontrib><title>Preferential Metabolic Activation of N-Nitrosopiperidine as Compared to Its Structural Homologue N-Nitrosopyrrolidine by Rat Nasal Mucosal Microsomes</title><title>Chemical research in toxicology</title><addtitle>Chem. Res. Toxicol</addtitle><description>N-Nitrosopiperidine (NPIP) is a potent rat nasal carcinogen whereas N-nitrosopyrrolidine (NPYR), a hepatic carcinogen, is weakly carcinogenic in the nose. NPIP and NPYR may be causative agents in human cancer. P450-catalyzed α-hydroxylation is the key activation pathway by which these nitrosamines elicit their carcinogenic effects. We hypothesize that the differences in NPIP and NPYR metabolic activation in the nasal cavity contribute to their differing carcinogenic activities. In this study, the kinetics of tritium-labeled NPIP or NPYR α-hydroxylation mediated by Sprague−Dawley rat nasal olfactory or respiratory microsomes were investigated. To compare α-hydroxylation rates of the two nitrosamines, tritiated 2-hydroxytetrahydro-2H-pyran and 2-hydroxy-5-methyltetrahydrofuran, the major NPIP α-hydroxylation products, and tritiated 2-hydroxytetrahydrofuran, the major NPYR α-hydroxylation product, were quantitated by HPLC with UV absorbance and radioflow detection. These microsomes catalyzed the α-hydroxylation of NPIP more efficiently than that of NPYR. K M values for NPIP were lower as compared to those for NPYR (13.9−34.7 vs 484−7660 μM). Furthermore, catalytic efficiencies (V max/K M) of NPIP were 20−37-fold higher than those of NPYR. Previous studies showed that P450 2A3, present in the rat nose, also exhibited this difference in catalytic efficiency. For both types of nasal microsomes, coumarin (100 μM), a P450 2A inhibitor, inhibited NPIP and NPYR α-hydroxylation from 63.8 to 98.5%. Furthermore, antibodies toward P450 2A6 inhibited nitrosamine α-hydroxylation in these microsomes from 68.8 to 78.4% whereas antibodies toward P450 2E1 did not inhibit these reactions. Further immunoinhibition studies suggest some role for P450 2G1 in NPIP metabolism by olfactory microsomes. In conclusion, olfactory and respiratory microsomes from rat nasal mucosa preferentially activate NPIP over NPYR with P450 2A3 likely playing a key role. These results are consistent with local metabolic activation of nitrosamines as a contributing factor in their tissue-specific carcinogenicity.</description><subject>Animals</subject><subject>Aryl Hydrocarbon Hydroxylases - antagonists &amp; inhibitors</subject><subject>Aryl Hydrocarbon Hydroxylases - metabolism</subject><subject>Catalysis</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Cytochrome P-450 CYP2A6</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Hydroxylation - drug effects</subject><subject>Immunoglobulin G - immunology</subject><subject>Immunoglobulin G - pharmacology</subject><subject>Kinetics</subject><subject>Male</subject><subject>Microsomes - drug effects</subject><subject>Microsomes - enzymology</subject><subject>Microsomes - metabolism</subject><subject>Mixed Function Oxygenases - antagonists &amp; inhibitors</subject><subject>Mixed Function Oxygenases - metabolism</subject><subject>Molecular Structure</subject><subject>N-Nitrosopiperidine</subject><subject>N-Nitrosopyrrolidine</subject><subject>N-Nitrosopyrrolidine - chemistry</subject><subject>N-Nitrosopyrrolidine - metabolism</subject><subject>N-Nitrosopyrrolidine - toxicity</subject><subject>Nasal Mucosa - cytology</subject><subject>Nasal Mucosa - drug effects</subject><subject>Nasal Mucosa - enzymology</subject><subject>Nasal Mucosa - metabolism</subject><subject>Nitrosamines - chemistry</subject><subject>Nitrosamines - metabolism</subject><subject>Nitrosamines - toxicity</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><issn>0893-228X</issn><issn>1520-5010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkU1PGzEQhi3UqgTaQ_9A5UuROCwd27vx7hGiEpBomvIh9WY5_qhMd9eL7a3ID-H_4pCI9tDTHOaZd0bPIPSRwAkBSr6kR2AllE21hyakolBUQOANmkDdsILS-uc-OojxHoBknL9D-6SsphXnZIKelsFYE0yfnGzxN5PkyrdO4VOV3B-ZnO-xt3hRLFwKPvrBDSY47XqDZcQz3w0yGI2Tx5cp4psURpXGkJMufOdb_2s0_8yuQ8jZL8OrNb6WCS9k3GwdlX-pTm24zsT36K2VbTQfdvUQ3Z1_vZ1dFFff55ez06tCshpSYWmp1ZRaRTRnVnOlTWOtLRk02gKwigCpV7apQRIKdTajJdE2q6obgJKwQ3S0zR2CfxhNTKJzUZm2lb3xYxSkIbypKcvg8RbcXBizMjEE18mwFgTE5gfi9QeZ_bQLHVed0X_JnfQMFFvAxWQeX_sy_BZTznglbpc3YvmDLvn8ei7OMv95y0sVxb0fQ5-d_GfxM2bGn1g</recordid><startdate>20031001</startdate><enddate>20031001</enddate><creator>Wong, Hansen L</creator><creator>Murphy, Sharon E</creator><creator>Hecht, Stephen S</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20031001</creationdate><title>Preferential Metabolic Activation of N-Nitrosopiperidine as Compared to Its Structural Homologue N-Nitrosopyrrolidine by Rat Nasal Mucosal Microsomes</title><author>Wong, Hansen L ; Murphy, Sharon E ; Hecht, Stephen S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a380t-f24dc62fc1d73fd7cde9fff4309df00351018bf980a1208520da1df4048900413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Aryl Hydrocarbon Hydroxylases - antagonists &amp; inhibitors</topic><topic>Aryl Hydrocarbon Hydroxylases - metabolism</topic><topic>Catalysis</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Cytochrome P-450 CYP2A6</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Hydroxylation - drug effects</topic><topic>Immunoglobulin G - immunology</topic><topic>Immunoglobulin G - pharmacology</topic><topic>Kinetics</topic><topic>Male</topic><topic>Microsomes - drug effects</topic><topic>Microsomes - enzymology</topic><topic>Microsomes - metabolism</topic><topic>Mixed Function Oxygenases - antagonists &amp; inhibitors</topic><topic>Mixed Function Oxygenases - metabolism</topic><topic>Molecular Structure</topic><topic>N-Nitrosopiperidine</topic><topic>N-Nitrosopyrrolidine</topic><topic>N-Nitrosopyrrolidine - chemistry</topic><topic>N-Nitrosopyrrolidine - metabolism</topic><topic>N-Nitrosopyrrolidine - toxicity</topic><topic>Nasal Mucosa - cytology</topic><topic>Nasal Mucosa - drug effects</topic><topic>Nasal Mucosa - enzymology</topic><topic>Nasal Mucosa - metabolism</topic><topic>Nitrosamines - chemistry</topic><topic>Nitrosamines - metabolism</topic><topic>Nitrosamines - toxicity</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wong, Hansen L</creatorcontrib><creatorcontrib>Murphy, Sharon E</creatorcontrib><creatorcontrib>Hecht, Stephen S</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Chemical research in toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wong, Hansen L</au><au>Murphy, Sharon E</au><au>Hecht, Stephen S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preferential Metabolic Activation of N-Nitrosopiperidine as Compared to Its Structural Homologue N-Nitrosopyrrolidine by Rat Nasal Mucosal Microsomes</atitle><jtitle>Chemical research in toxicology</jtitle><addtitle>Chem. Res. Toxicol</addtitle><date>2003-10-01</date><risdate>2003</risdate><volume>16</volume><issue>10</issue><spage>1298</spage><epage>1305</epage><pages>1298-1305</pages><issn>0893-228X</issn><eissn>1520-5010</eissn><abstract>N-Nitrosopiperidine (NPIP) is a potent rat nasal carcinogen whereas N-nitrosopyrrolidine (NPYR), a hepatic carcinogen, is weakly carcinogenic in the nose. NPIP and NPYR may be causative agents in human cancer. P450-catalyzed α-hydroxylation is the key activation pathway by which these nitrosamines elicit their carcinogenic effects. We hypothesize that the differences in NPIP and NPYR metabolic activation in the nasal cavity contribute to their differing carcinogenic activities. In this study, the kinetics of tritium-labeled NPIP or NPYR α-hydroxylation mediated by Sprague−Dawley rat nasal olfactory or respiratory microsomes were investigated. To compare α-hydroxylation rates of the two nitrosamines, tritiated 2-hydroxytetrahydro-2H-pyran and 2-hydroxy-5-methyltetrahydrofuran, the major NPIP α-hydroxylation products, and tritiated 2-hydroxytetrahydrofuran, the major NPYR α-hydroxylation product, were quantitated by HPLC with UV absorbance and radioflow detection. These microsomes catalyzed the α-hydroxylation of NPIP more efficiently than that of NPYR. K M values for NPIP were lower as compared to those for NPYR (13.9−34.7 vs 484−7660 μM). Furthermore, catalytic efficiencies (V max/K M) of NPIP were 20−37-fold higher than those of NPYR. Previous studies showed that P450 2A3, present in the rat nose, also exhibited this difference in catalytic efficiency. For both types of nasal microsomes, coumarin (100 μM), a P450 2A inhibitor, inhibited NPIP and NPYR α-hydroxylation from 63.8 to 98.5%. Furthermore, antibodies toward P450 2A6 inhibited nitrosamine α-hydroxylation in these microsomes from 68.8 to 78.4% whereas antibodies toward P450 2E1 did not inhibit these reactions. Further immunoinhibition studies suggest some role for P450 2G1 in NPIP metabolism by olfactory microsomes. In conclusion, olfactory and respiratory microsomes from rat nasal mucosa preferentially activate NPIP over NPYR with P450 2A3 likely playing a key role. These results are consistent with local metabolic activation of nitrosamines as a contributing factor in their tissue-specific carcinogenicity.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>14565771</pmid><doi>10.1021/tx0340495</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0893-228X
ispartof Chemical research in toxicology, 2003-10, Vol.16 (10), p.1298-1305
issn 0893-228X
1520-5010
language eng
recordid cdi_proquest_miscellaneous_19179823
source MEDLINE; ACS Publications
subjects Animals
Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors
Aryl Hydrocarbon Hydroxylases - metabolism
Catalysis
Chromatography, High Pressure Liquid
Cytochrome P-450 CYP2A6
Enzyme Inhibitors - pharmacology
Humans
Hydroxylation - drug effects
Immunoglobulin G - immunology
Immunoglobulin G - pharmacology
Kinetics
Male
Microsomes - drug effects
Microsomes - enzymology
Microsomes - metabolism
Mixed Function Oxygenases - antagonists & inhibitors
Mixed Function Oxygenases - metabolism
Molecular Structure
N-Nitrosopiperidine
N-Nitrosopyrrolidine
N-Nitrosopyrrolidine - chemistry
N-Nitrosopyrrolidine - metabolism
N-Nitrosopyrrolidine - toxicity
Nasal Mucosa - cytology
Nasal Mucosa - drug effects
Nasal Mucosa - enzymology
Nasal Mucosa - metabolism
Nitrosamines - chemistry
Nitrosamines - metabolism
Nitrosamines - toxicity
Rats
Rats, Sprague-Dawley
title Preferential Metabolic Activation of N-Nitrosopiperidine as Compared to Its Structural Homologue N-Nitrosopyrrolidine by Rat Nasal Mucosal Microsomes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T20%3A45%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preferential%20Metabolic%20Activation%20of%20N-Nitrosopiperidine%20as%20Compared%20to%20Its%20Structural%20Homologue%20N-Nitrosopyrrolidine%20by%20Rat%20Nasal%20Mucosal%20Microsomes&rft.jtitle=Chemical%20research%20in%20toxicology&rft.au=Wong,%20Hansen%20L&rft.date=2003-10-01&rft.volume=16&rft.issue=10&rft.spage=1298&rft.epage=1305&rft.pages=1298-1305&rft.issn=0893-228X&rft.eissn=1520-5010&rft_id=info:doi/10.1021/tx0340495&rft_dat=%3Cproquest_cross%3E19179823%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19179823&rft_id=info:pmid/14565771&rfr_iscdi=true